Clinical Trials Directory

Trials / Completed

CompletedNCT02832154

Internet-Delivered Positive Affect Program in Managing Emotion in Young Adult Cancer Survivors

Enhancing Management of Patient Reported Outcomes With Emotion Regulation (EMPOWER)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years – 39 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies how well an internet-delivered positive affect (PA) intervention works in managing emotion in young adult cancer survivors. An internet-delivered PA intervention may teach younger cancer survivors healthy coping skills and help doctors to learn more about what effects mood may have on the health and well-being of young adults with cancer.

Detailed description

PRIMARY OBJECTIVES: I. To adapt an individualized positive affect intervention that was developed for newly diagnosed HIV patients to use with young adult cancer survivors. II. To pilot test the positive affect intervention with young adult cancer survivors to determine its feasibility and acceptability. SECONDARY OBJECTIVES: I. To describe health related quality of life, psychological well-being, daily emotion reports, and health behaviors in young adult cancer survivors. OUTLINE: Patients complete an initial online questionnaire lasting about 25-30 minutes. Patients complete an internet-delivered PA program during weeks 3-8. Each week consists of didactic material and 20-30 minutes of daily online exercises. After completion of study, patients are followed up at 1 and 12 weeks.

Conditions

Interventions

TypeNameDescription
OTHERInternet-Based InterventionComplete online PA program
PROCEDUREQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2017-04-21
Primary completion
2019-04-23
Completion
2020-04-23
First posted
2016-07-14
Last updated
2020-07-16
Results posted
2020-07-16

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02832154. Inclusion in this directory is not an endorsement.